Edwards Lifesciences (EW) Numbers Trimmed at Jeffereis on Earlier CoreValve Approval

October 30, 2013 1:29 PM

Jefferies analsyt Raj Denhoy trimmed estimates and its price target on Buy-rated Edwards Lifesciences (NYSE: EW) from $85 to $80 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found